# Estrogen Clearance & Conjugation — Selected References

- **CYP3A4*22 (rs35599367):** reduced hepatic expression/activity and clinical PK effects (reviewed in PGx overviews). See allele definition & clinical summaries in PharmVar/PharmGKB; and population/PK studies showing decreased 3A4 expression. 
- **CYP3A5*3 (rs776746):** non-expressor; shifts metabolic burden to CYP3A4 (standard PGx texts & PharmVar).
- **UGT1A1*28 (rs8175347; rs887829 tag):** lower expression and reduced glucuronidation; Gilbert’s; effects on estrogenic substrates incl. raloxifene; SN-38 data.  
- **SULT1E1 polymorphisms (incl. rs3736599 promoter):** can reduce estrogen sulfation capacity (population / functional reports).  
- **SHBG variants (rs1799941, rs12150660, rs6259):** robustly shift SHBG levels; GWAS/meta linking SHBG locus with testosterone and metabolic traits.

